The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Nucleic-Acid Based Gene Therapeutics Market Research Report 2025
Synopsis
Nucleic acid-based molecules are utilized as research tools within the broad borders of gene therapy and the emerging field of molecular medicine.
The global Nucleic-Acid Based Gene Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Nucleic-Acid Based Gene Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nucleic-Acid Based Gene Therapeutics.
Report Scope
The Nucleic-Acid Based Gene Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nucleic-Acid Based Gene Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nucleic-Acid Based Gene Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Wave Life Sciences
Phylogica
Benitec Biopharma
Celsion
Copernicus Therapeutics
Segment by Type
DNA
RNA
Segment by Application
Academic and Government Research Institutes
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Hospitals and Diagnostic Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nucleic-Acid Based Gene Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Nucleic acid-based molecules are utilized as research tools within the broad borders of gene therapy and the emerging field of molecular medicine.
The global Nucleic-Acid Based Gene Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Nucleic-Acid Based Gene Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nucleic-Acid Based Gene Therapeutics.
Report Scope
The Nucleic-Acid Based Gene Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nucleic-Acid Based Gene Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nucleic-Acid Based Gene Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Wave Life Sciences
Phylogica
Benitec Biopharma
Celsion
Copernicus Therapeutics
Segment by Type
DNA
RNA
Segment by Application
Academic and Government Research Institutes
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Hospitals and Diagnostic Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nucleic-Acid Based Gene Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nucleic-Acid Based Gene Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 DNA
1.2.3 RNA
1.3 Market by Application
1.3.1 Global Nucleic-Acid Based Gene Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Academic and Government Research Institutes
1.3.3 Pharmaceutical and Biotechnology Companies
1.3.4 Contract Research Organizations
1.3.5 Hospitals and Diagnostic Centers
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nucleic-Acid Based Gene Therapeutics Market Perspective (2019-2030)
2.2 Nucleic-Acid Based Gene Therapeutics Growth Trends by Region
2.2.1 Global Nucleic-Acid Based Gene Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Nucleic-Acid Based Gene Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Nucleic-Acid Based Gene Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Nucleic-Acid Based Gene Therapeutics Market Dynamics
2.3.1 Nucleic-Acid Based Gene Therapeutics Industry Trends
2.3.2 Nucleic-Acid Based Gene Therapeutics Market Drivers
2.3.3 Nucleic-Acid Based Gene Therapeutics Market Challenges
2.3.4 Nucleic-Acid Based Gene Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nucleic-Acid Based Gene Therapeutics Players by Revenue
3.1.1 Global Top Nucleic-Acid Based Gene Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Nucleic-Acid Based Gene Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nucleic-Acid Based Gene Therapeutics Revenue
3.4 Global Nucleic-Acid Based Gene Therapeutics Market Concentration Ratio
3.4.1 Global Nucleic-Acid Based Gene Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nucleic-Acid Based Gene Therapeutics Revenue in 2023
3.5 Nucleic-Acid Based Gene Therapeutics Key Players Head office and Area Served
3.6 Key Players Nucleic-Acid Based Gene Therapeutics Product Solution and Service
3.7 Date of Enter into Nucleic-Acid Based Gene Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nucleic-Acid Based Gene Therapeutics Breakdown Data by Type
4.1 Global Nucleic-Acid Based Gene Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Nucleic-Acid Based Gene Therapeutics Forecasted Market Size by Type (2025-2030)
5 Nucleic-Acid Based Gene Therapeutics Breakdown Data by Application
5.1 Global Nucleic-Acid Based Gene Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Nucleic-Acid Based Gene Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Nucleic-Acid Based Gene Therapeutics Market Size (2019-2030)
6.2 North America Nucleic-Acid Based Gene Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Nucleic-Acid Based Gene Therapeutics Market Size by Country (2019-2024)
6.4 North America Nucleic-Acid Based Gene Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nucleic-Acid Based Gene Therapeutics Market Size (2019-2030)
7.2 Europe Nucleic-Acid Based Gene Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Nucleic-Acid Based Gene Therapeutics Market Size by Country (2019-2024)
7.4 Europe Nucleic-Acid Based Gene Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nucleic-Acid Based Gene Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Nucleic-Acid Based Gene Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Nucleic-Acid Based Gene Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Nucleic-Acid Based Gene Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nucleic-Acid Based Gene Therapeutics Market Size (2019-2030)
9.2 Latin America Nucleic-Acid Based Gene Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Nucleic-Acid Based Gene Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Nucleic-Acid Based Gene Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nucleic-Acid Based Gene Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Nucleic-Acid Based Gene Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Nucleic-Acid Based Gene Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Nucleic-Acid Based Gene Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Wave Life Sciences
11.1.1 Wave Life Sciences Company Detail
11.1.2 Wave Life Sciences Business Overview
11.1.3 Wave Life Sciences Nucleic-Acid Based Gene Therapeutics Introduction
11.1.4 Wave Life Sciences Revenue in Nucleic-Acid Based Gene Therapeutics Business (2019-2024)
11.1.5 Wave Life Sciences Recent Development
11.2 Phylogica
11.2.1 Phylogica Company Detail
11.2.2 Phylogica Business Overview
11.2.3 Phylogica Nucleic-Acid Based Gene Therapeutics Introduction
11.2.4 Phylogica Revenue in Nucleic-Acid Based Gene Therapeutics Business (2019-2024)
11.2.5 Phylogica Recent Development
11.3 Benitec Biopharma
11.3.1 Benitec Biopharma Company Detail
11.3.2 Benitec Biopharma Business Overview
11.3.3 Benitec Biopharma Nucleic-Acid Based Gene Therapeutics Introduction
11.3.4 Benitec Biopharma Revenue in Nucleic-Acid Based Gene Therapeutics Business (2019-2024)
11.3.5 Benitec Biopharma Recent Development
11.4 Celsion
11.4.1 Celsion Company Detail
11.4.2 Celsion Business Overview
11.4.3 Celsion Nucleic-Acid Based Gene Therapeutics Introduction
11.4.4 Celsion Revenue in Nucleic-Acid Based Gene Therapeutics Business (2019-2024)
11.4.5 Celsion Recent Development
11.5 Copernicus Therapeutics
11.5.1 Copernicus Therapeutics Company Detail
11.5.2 Copernicus Therapeutics Business Overview
11.5.3 Copernicus Therapeutics Nucleic-Acid Based Gene Therapeutics Introduction
11.5.4 Copernicus Therapeutics Revenue in Nucleic-Acid Based Gene Therapeutics Business (2019-2024)
11.5.5 Copernicus Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Nucleic-Acid Based Gene Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of DNA
Table 3. Key Players of RNA
Table 4. Global Nucleic-Acid Based Gene Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Nucleic-Acid Based Gene Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Nucleic-Acid Based Gene Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Nucleic-Acid Based Gene Therapeutics Market Share by Region (2019-2024)
Table 8. Global Nucleic-Acid Based Gene Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Nucleic-Acid Based Gene Therapeutics Market Share by Region (2025-2030)
Table 10. Nucleic-Acid Based Gene Therapeutics Market Trends
Table 11. Nucleic-Acid Based Gene Therapeutics Market Drivers
Table 12. Nucleic-Acid Based Gene Therapeutics Market Challenges
Table 13. Nucleic-Acid Based Gene Therapeutics Market Restraints
Table 14. Global Nucleic-Acid Based Gene Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Nucleic-Acid Based Gene Therapeutics Market Share by Players (2019-2024)
Table 16. Global Top Nucleic-Acid Based Gene Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic-Acid Based Gene Therapeutics as of 2023)
Table 17. Ranking of Global Top Nucleic-Acid Based Gene Therapeutics Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Nucleic-Acid Based Gene Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Nucleic-Acid Based Gene Therapeutics Product Solution and Service
Table 21. Date of Enter into Nucleic-Acid Based Gene Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Nucleic-Acid Based Gene Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Type (2019-2024)
Table 25. Global Nucleic-Acid Based Gene Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Type (2025-2030)
Table 27. Global Nucleic-Acid Based Gene Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Application (2019-2024)
Table 29. Global Nucleic-Acid Based Gene Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Application (2025-2030)
Table 31. North America Nucleic-Acid Based Gene Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Nucleic-Acid Based Gene Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Nucleic-Acid Based Gene Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Nucleic-Acid Based Gene Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Nucleic-Acid Based Gene Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Nucleic-Acid Based Gene Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Nucleic-Acid Based Gene Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Nucleic-Acid Based Gene Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Nucleic-Acid Based Gene Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Nucleic-Acid Based Gene Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Nucleic-Acid Based Gene Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Nucleic-Acid Based Gene Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Nucleic-Acid Based Gene Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Nucleic-Acid Based Gene Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Nucleic-Acid Based Gene Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 46. Wave Life Sciences Company Detail
Table 47. Wave Life Sciences Business Overview
Table 48. Wave Life Sciences Nucleic-Acid Based Gene Therapeutics Product
Table 49. Wave Life Sciences Revenue in Nucleic-Acid Based Gene Therapeutics Business (2019-2024) & (US$ Million)
Table 50. Wave Life Sciences Recent Development
Table 51. Phylogica Company Detail
Table 52. Phylogica Business Overview
Table 53. Phylogica Nucleic-Acid Based Gene Therapeutics Product
Table 54. Phylogica Revenue in Nucleic-Acid Based Gene Therapeutics Business (2019-2024) & (US$ Million)
Table 55. Phylogica Recent Development
Table 56. Benitec Biopharma Company Detail
Table 57. Benitec Biopharma Business Overview
Table 58. Benitec Biopharma Nucleic-Acid Based Gene Therapeutics Product
Table 59. Benitec Biopharma Revenue in Nucleic-Acid Based Gene Therapeutics Business (2019-2024) & (US$ Million)
Table 60. Benitec Biopharma Recent Development
Table 61. Celsion Company Detail
Table 62. Celsion Business Overview
Table 63. Celsion Nucleic-Acid Based Gene Therapeutics Product
Table 64. Celsion Revenue in Nucleic-Acid Based Gene Therapeutics Business (2019-2024) & (US$ Million)
Table 65. Celsion Recent Development
Table 66. Copernicus Therapeutics Company Detail
Table 67. Copernicus Therapeutics Business Overview
Table 68. Copernicus Therapeutics Nucleic-Acid Based Gene Therapeutics Product
Table 69. Copernicus Therapeutics Revenue in Nucleic-Acid Based Gene Therapeutics Business (2019-2024) & (US$ Million)
Table 70. Copernicus Therapeutics Recent Development
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nucleic-Acid Based Gene Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Nucleic-Acid Based Gene Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. DNA Features
Figure 4. RNA Features
Figure 5. Global Nucleic-Acid Based Gene Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Nucleic-Acid Based Gene Therapeutics Market Share by Application: 2023 VS 2030
Figure 7. Academic and Government Research Institutes Case Studies
Figure 8. Pharmaceutical and Biotechnology Companies Case Studies
Figure 9. Contract Research Organizations Case Studies
Figure 10. Hospitals and Diagnostic Centers Case Studies
Figure 11. Others Case Studies
Figure 12. Nucleic-Acid Based Gene Therapeutics Report Years Considered
Figure 13. Global Nucleic-Acid Based Gene Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Nucleic-Acid Based Gene Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Nucleic-Acid Based Gene Therapeutics Market Share by Region: 2023 VS 2030
Figure 16. Global Nucleic-Acid Based Gene Therapeutics Market Share by Players in 2023
Figure 17. Global Top Nucleic-Acid Based Gene Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic-Acid Based Gene Therapeutics as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Nucleic-Acid Based Gene Therapeutics Revenue in 2023
Figure 19. North America Nucleic-Acid Based Gene Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Nucleic-Acid Based Gene Therapeutics Market Share by Country (2019-2030)
Figure 21. United States Nucleic-Acid Based Gene Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Nucleic-Acid Based Gene Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Nucleic-Acid Based Gene Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Nucleic-Acid Based Gene Therapeutics Market Share by Country (2019-2030)
Figure 25. Germany Nucleic-Acid Based Gene Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Nucleic-Acid Based Gene Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Nucleic-Acid Based Gene Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Nucleic-Acid Based Gene Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Nucleic-Acid Based Gene Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Nucleic-Acid Based Gene Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Nucleic-Acid Based Gene Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Nucleic-Acid Based Gene Therapeutics Market Share by Region (2019-2030)
Figure 33. China Nucleic-Acid Based Gene Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Nucleic-Acid Based Gene Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Nucleic-Acid Based Gene Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Nucleic-Acid Based Gene Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Nucleic-Acid Based Gene Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Nucleic-Acid Based Gene Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Nucleic-Acid Based Gene Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Nucleic-Acid Based Gene Therapeutics Market Share by Country (2019-2030)
Figure 41. Mexico Nucleic-Acid Based Gene Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Nucleic-Acid Based Gene Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Nucleic-Acid Based Gene Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Nucleic-Acid Based Gene Therapeutics Market Share by Country (2019-2030)
Figure 45. Turkey Nucleic-Acid Based Gene Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Nucleic-Acid Based Gene Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Wave Life Sciences Revenue Growth Rate in Nucleic-Acid Based Gene Therapeutics Business (2019-2024)
Figure 48. Phylogica Revenue Growth Rate in Nucleic-Acid Based Gene Therapeutics Business (2019-2024)
Figure 49. Benitec Biopharma Revenue Growth Rate in Nucleic-Acid Based Gene Therapeutics Business (2019-2024)
Figure 50. Celsion Revenue Growth Rate in Nucleic-Acid Based Gene Therapeutics Business (2019-2024)
Figure 51. Copernicus Therapeutics Revenue Growth Rate in Nucleic-Acid Based Gene Therapeutics Business (2019-2024)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
